sodium chloride

Generic: sodium chloride

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sodium chloride
Generic Name sodium chloride
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

sodium chloride 4 meq/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-099
Product ID 63323-099_f5197532-af45-42c9-919b-30d00276650e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217796
Listing Expiration 2026-12-31
Marketing Start 2023-07-11

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323099
Hyphenated Format 63323-099

Supplemental Identifiers

RxCUI
313016
UPC
0363323099039
UNII
451W47IQ8X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium chloride (source: ndc)
Generic Name sodium chloride (source: ndc)
Application Number ANDA217796 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 4 meq/mL
source: ndc
Packaging
  • 10 VIAL, PLASTIC in 1 TRAY (63323-099-63) / 200 mL in 1 VIAL, PLASTIC (63323-099-03)
source: ndc

Packages (1)

63323-099-63 10 VIAL, PLASTIC in 1 TRAY (63323-099-63) / 200 mL in 1 VIAL, PLASTIC (63323-099-03)

Ingredients (1)

sodium chloride (4 meq/mL)

Linked Drug Pages (1)

Sodium Chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f5197532-af45-42c9-919b-30d00276650e", "openfda": {"upc": ["0363323099039"], "unii": ["451W47IQ8X"], "rxcui": ["313016"], "spl_set_id": ["b6e33138-841a-471f-a934-c4086cbc23f6"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, PLASTIC in 1 TRAY (63323-099-63)  / 200 mL in 1 VIAL, PLASTIC (63323-099-03)", "package_ndc": "63323-099-63", "marketing_start_date": "20230711"}], "brand_name": "Sodium Chloride", "product_id": "63323-099_f5197532-af45-42c9-919b-30d00276650e", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-099", "generic_name": "Sodium Chloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Chloride", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "4 meq/mL"}], "application_number": "ANDA217796", "marketing_category": "ANDA", "marketing_start_date": "20230711", "listing_expiration_date": "20261231"}